Austco Healthcare Ltd (ASX:AHC) provides nurse-call and clinical-communications technology, led by its Tacera platform, which connects patients, nurses and clinical systems within hospitals and aged-care facilities. As healthcare providers digitise workflows and seek to improve patient safety and staff efficiency, Demand for such systems — and the recurring software and maintenance Revenue they generate — is growing.

Record FY26 revenue and a sharp profit increase have raised the question of whether the market is underestimating this healthcare growth story.

Latest Development

For FY26, Austco reported record revenue of A$94.2 million, up 15.8%, with software and software-maintenance-agreement revenue rising 19% to A$11.4 million, supporting more than 5,000 healthcare facilities. Net profit after tax jumped 51.8% to A$9.0 million, and the unfilled contracted order book stood at A$51.2 million as at mid-August, up 13% from the end of June.

Recent wins included A$1.85 million of phase-one purchase orders for a Tacera retrofit at Hospital Israelita Albert Einstein in Brazil and a A$1.1 million nurse-call contract for Warrnambool Base Hospital. The company finished with A$16.3 million in cash and no material borrowings, retaining cash for growth rather than paying a dividend.

The A$51.2 million order book provides forward revenue visibility, and a debt-free Balance Sheet with A$16.3 million of cash gives the company flexibility to fund organic and acquisition-led growth.

What Could Drive the Shares Next?

Catalysts include conversion of the order book into revenue, continued growth in recurring software and maintenance revenue, new hospital wins across its markets, and any acquisitions funded by its cash balance. Evidence that Recurring Revenue is becoming a larger share of the mix would strengthen the case.

Sustained profit growth on the back of the order book would be the clearest positive signal.

Risks Investors Should Watch

Order-book conversion and the timing of large hospital projects can make revenue lumpy. Demand depends on healthcare Capital spending, which can be cyclical, and competition exists in clinical-communications technology.

The decision to retain cash rather than pay a Dividend reflects a growth focus, so execution on that growth is what investors are backing.

Investor Takeaway

Austco Healthcare delivered record FY26 revenue of A$94.2 million, a 51.8% jump in net profit, growing recurring revenue and a A$51.2 million order book, all debt-free. Whether the market is underestimating the story depends on converting that order book and growing recurring revenue. Revenue, recurring-revenue growth and order-book conversion are the things to watch.